O	0	6	CX3CR1	CX3CR1	NN	B-NP
O	6	7	-	-	HYPH	I-NP
O	7	16	dependent	dependent	JJ	I-NP
B-Cell	17	27	subretinal	subretinal	JJ	I-NP
I-Cell	28	37	microglia	microglia	NN	I-NP
I-Cell	38	42	cell	cell	NN	I-NP
O	43	55	accumulation	accumulation	NN	I-NP
O	56	58	is	be	VBZ	B-VP
O	59	69	associated	associate	VBN	I-VP
O	70	74	with	with	IN	B-PP
O	75	83	cardinal	cardinal	JJ	B-NP
O	84	92	features	feature	NNS	I-NP
O	93	95	of	of	IN	B-PP
O	96	99	age	age	NN	B-NP
O	99	100	-	-	HYPH	O
O	100	107	related	relate	VBN	B-NP
B-Tissue	108	115	macular	macular	JJ	I-NP
O	116	128	degeneration	degeneration	NN	I-NP
O	128	129	.	.	.	O

O	130	133	The	The	DT	B-NP
O	134	138	role	role	NN	I-NP
O	139	141	of	of	IN	B-PP
B-Cell	142	149	retinal	retinal	JJ	B-NP
I-Cell	150	160	microglial	microglial	JJ	I-NP
I-Cell	161	166	cells	cell	NNS	I-NP
O	167	168	(	(	(	O
B-Cell	168	171	MCs	MC	NNS	B-NP
O	171	172	)	)	)	O
O	173	175	in	in	IN	B-PP
O	176	179	age	age	NN	B-NP
O	179	180	-	-	HYPH	O
O	180	187	related	relate	VBN	B-VP
B-Tissue	188	195	macular	macular	JJ	B-NP
O	196	208	degeneration	degeneration	NN	I-NP
O	209	210	(	(	(	O
O	210	213	AMD	AMD	NN	B-NP
O	213	214	)	)	)	O
O	215	217	is	be	VBZ	B-VP
O	218	225	unclear	unclear	JJ	B-ADJP
O	225	226	.	.	.	O

O	227	231	Here	Here	RB	B-ADVP
O	232	234	we	we	PRP	B-NP
O	235	247	demonstrated	demonstrate	VBD	B-VP
O	248	252	that	that	IN	B-SBAR
O	253	256	all	all	DT	B-NP
B-Cell	257	264	retinal	retinal	JJ	I-NP
I-Cell	265	268	MCs	MC	NNS	I-NP
O	269	276	express	express	VBP	B-VP
O	277	281	CX3C	CX3C	NN	B-NP
O	282	291	chemokine	chemokine	NN	I-NP
O	292	300	receptor	receptor	NN	I-NP
O	301	302	1	1	CD	I-NP
O	303	304	(	(	(	O
O	304	310	CX3CR1	CX3CR1	NN	B-NP
O	310	311	)	)	)	O
O	312	315	and	and	CC	O
O	316	320	that	that	IN	B-SBAR
O	321	333	homozygosity	homozygosity	NN	B-NP
O	334	337	for	for	IN	B-PP
O	338	341	the	the	DT	B-NP
O	342	348	CX3CR1	CX3CR1	NN	I-NP
O	349	353	M280	M280	NN	I-NP
O	354	360	allele	allele	NN	I-NP
O	360	361	,	,	,	O
O	362	367	which	which	WDT	B-NP
O	368	370	is	be	VBZ	B-VP
O	371	381	associated	associate	VBN	I-VP
O	382	386	with	with	IN	B-PP
O	387	395	impaired	impaired	JJ	B-NP
B-Cell	396	400	cell	cell	NN	I-NP
O	401	410	migration	migration	NN	I-NP
O	410	411	,	,	,	O
O	412	421	increases	increase	VBZ	B-VP
O	422	425	the	the	DT	B-NP
O	426	430	risk	risk	NN	I-NP
O	431	433	of	of	IN	B-PP
O	434	437	AMD	AMD	NN	B-NP
O	437	438	.	.	.	O

O	439	441	In	In	IN	B-PP
O	442	448	humans	human	NNS	B-NP
O	449	453	with	with	IN	B-PP
O	454	457	AMD	AMD	NN	B-NP
O	457	458	,	,	,	O
B-Cell	459	462	MCs	MC	NNS	B-NP
O	463	474	accumulated	accumulate	VBN	B-VP
O	475	477	in	in	IN	B-PP
O	478	481	the	the	DT	B-NP
B-Immaterial_anatomical_entity	482	492	subretinal	subretinal	JJ	I-NP
I-Immaterial_anatomical_entity	493	498	space	space	NN	I-NP
O	499	501	at	at	IN	B-PP
B-Multi-tissue_structure	502	507	sites	site	NNS	B-NP
O	508	510	of	of	IN	B-PP
B-Multi-tissue_structure	511	518	retinal	retinal	JJ	B-NP
O	519	531	degeneration	degeneration	NN	I-NP
O	532	535	and	and	CC	O
B-Multi-tissue_structure	536	545	choroidal	choroidal	JJ	B-NP
O	546	564	neovascularization	neovascularization	NN	I-NP
O	565	566	(	(	(	O
O	566	569	CNV	CNV	NN	B-NP
O	569	570	)	)	)	O
O	570	571	.	.	.	O

O	572	574	In	In	IN	B-PP
O	575	581	CX3CR1	CX3CR1	NN	B-NP
O	581	582	-	-	HYPH	B-NP
O	582	591	deficient	deficient	JJ	I-NP
O	592	596	mice	mouse	NNS	I-NP
O	596	597	,	,	,	O
B-Cell	598	601	MCs	MC	NNS	B-NP
O	602	613	accumulated	accumulate	VBD	B-VP
B-Immaterial_anatomical_entity	614	626	subretinally	subretinally	RB	B-ADVP
O	627	631	with	with	IN	B-PP
O	632	635	age	age	NN	B-NP
O	636	639	and	and	CC	I-NP
O	640	646	albino	albino	NN	I-NP
O	647	657	background	background	NN	I-NP
O	658	661	and	and	CC	B-PP
O	662	667	after	after	IN	B-PP
O	668	673	laser	laser	NN	B-NP
O	674	680	impact	impact	NN	I-NP
O	681	690	preceding	precede	VBG	B-VP
B-Multi-tissue_structure	691	698	retinal	retinal	JJ	B-NP
O	699	711	degeneration	degeneration	NN	I-NP
O	711	712	.	.	.	O

O	713	720	Raising	Raise	VBG	B-VP
O	721	724	the	the	DT	B-NP
O	725	731	albino	albino	NN	I-NP
O	732	736	mice	mouse	NNS	I-NP
O	737	739	in	in	IN	B-PP
O	740	743	the	the	DT	B-NP
O	744	748	dark	dark	NN	I-NP
O	749	758	prevented	prevent	VBD	B-VP
O	759	763	both	both	DT	B-NP
O	764	770	events	event	NNS	I-NP
O	770	771	.	.	.	O

O	772	775	The	The	DT	B-NP
O	776	786	appearance	appearance	NN	I-NP
O	787	789	of	of	IN	B-PP
O	790	795	lipid	lipid	NN	B-NP
O	795	796	-	-	HYPH	O
O	796	803	bloated	bloat	VBN	B-NP
B-Cell	804	814	subretinal	subretinal	JJ	I-NP
I-Cell	815	818	MCs	MC	NNS	I-NP
O	819	822	was	be	VBD	B-VP
B-Pathological_formation	823	829	drusen	drusen	VBN	I-VP
O	829	830	-	-	HYPH	B-ADVP
O	830	834	like	like	JJ	B-ADJP
O	835	837	on	on	IN	B-PP
O	838	848	funduscopy	funduscopy	NN	B-NP
O	849	851	of	of	IN	B-PP
O	852	861	senescent	senescent	JJ	B-NP
O	862	866	mice	mouse	NNS	I-NP
O	866	867	,	,	,	O
O	868	871	and	and	CC	O
O	872	878	CX3CR1	CX3CR1	NN	B-NP
O	878	879	-	-	HYPH	B-NP
O	879	888	dependent	dependent	JJ	I-NP
B-Cell	889	891	MC	MC	NN	I-NP
O	892	904	accumulation	accumulation	NN	I-NP
O	905	908	was	be	VBD	B-VP
O	909	919	associated	associate	VBN	I-VP
O	920	924	with	with	IN	B-PP
O	925	927	an	an	DT	B-NP
O	928	940	exacerbation	exacerbation	NN	I-NP
O	941	943	of	of	IN	B-PP
O	944	956	experimental	experimental	JJ	B-NP
O	957	960	CNV	CNV	NN	I-NP
O	960	961	.	.	.	O

O	962	967	These	These	DT	B-NP
O	968	975	results	result	NNS	I-NP
O	976	980	show	show	VBP	B-VP
O	981	985	that	that	IN	B-SBAR
O	986	992	CX3CR1	CX3CR1	NN	B-NP
O	992	993	-	-	HYPH	B-NP
O	993	1002	dependent	dependent	JJ	I-NP
O	1003	1015	accumulation	accumulation	NN	I-NP
O	1016	1018	of	of	IN	B-PP
B-Cell	1019	1029	subretinal	subretinal	JJ	B-NP
I-Cell	1030	1033	MCs	MC	NNS	I-NP
O	1034	1040	evokes	evoke	VBZ	B-VP
O	1041	1049	cardinal	cardinal	JJ	B-NP
O	1050	1058	features	feature	NNS	I-NP
O	1059	1061	of	of	IN	B-PP
O	1062	1065	AMD	AMD	NN	B-NP
O	1065	1066	.	.	.	O

O	1067	1072	These	These	DT	B-NP
O	1073	1081	findings	finding	NNS	I-NP
O	1082	1088	reveal	reveal	VBP	B-VP
O	1089	1093	what	what	WP	B-NP
O	1094	1096	we	we	PRP	B-NP
O	1097	1104	believe	believe	VBP	B-VP
O	1105	1107	to	to	TO	I-VP
O	1108	1110	be	be	VB	I-VP
O	1111	1112	a	a	DT	B-NP
O	1113	1118	novel	novel	JJ	I-NP
O	1119	1129	pathogenic	pathogenic	JJ	I-NP
O	1130	1137	process	process	NN	I-NP
O	1138	1142	with	with	IN	B-PP
O	1143	1152	important	important	JJ	B-NP
O	1153	1165	implications	implication	NNS	I-NP
O	1166	1169	for	for	IN	B-PP
O	1170	1173	the	the	DT	B-NP
O	1174	1185	development	development	NN	I-NP
O	1186	1188	of	of	IN	B-PP
O	1189	1192	new	new	JJ	B-NP
O	1193	1202	therapies	therapy	NNS	I-NP
O	1203	1206	for	for	IN	B-PP
O	1207	1210	AMD	AMD	NN	B-NP
O	1210	1211	.	.	.	O

